XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 104 filers reported holding XENON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,256 | -47.9% | 1,149,168 | -41.3% | 0.15% | -43.5% |
| Q2 2023 | $75,404 | +18.2% | 1,958,540 | +9.9% | 0.26% | +13.0% |
| Q1 2023 | $63,800 | -23.8% | 1,782,611 | -16.1% | 0.23% | -23.3% |
| Q4 2022 | $83,749 | -99.9% | 2,124,009 | +11.0% | 0.30% | +19.0% |
| Q3 2022 | $69,090,000 | +22.3% | 1,913,861 | +3.0% | 0.25% | +26.0% |
| Q2 2022 | $56,508,000 | +3.2% | 1,857,596 | +3.7% | 0.20% | +37.0% |
| Q1 2022 | $54,743,000 | -2.4% | 1,790,743 | -0.2% | 0.15% | +14.1% |
| Q4 2021 | $56,079,000 | +870.1% | 1,795,080 | +374.4% | 0.13% | +814.3% |
| Q3 2021 | $5,781,000 | -19.3% | 378,358 | -1.7% | 0.01% | -17.6% |
| Q2 2021 | $7,164,000 | -4.4% | 384,725 | -8.1% | 0.02% | -10.5% |
| Q1 2021 | $7,492,000 | – | 418,550 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |